Skip Navigation

Healthcare Innovation in the 21st Century: HHS’ Dynamic Role in the Biomedical and Device Development Process.

On November 14, Deputy Secretary Troy hosted a conference on healthcare innovation. The conference featured presentations from senior officials from the National Institutes of Health (NIH), the Food and Drug Administration (FDA), the Center for Medicare & Medicaid Services (CMS), and the Agency for Healthcare Research and Quality (AHRQ) will highlight each agency’s role in facilitating the development of innovative medical technologies. Topics discussed included:

  • The role of basic and clinical research conducted and supported by the NIH in the development of new products;
  • FDA’s efforts to use state-of-the art science in support of medical product development, as well as to promote consistency and efficiency in medical product review;
  • CMS’ perspective on the challenges innovators face in current reimbursement and coverage processes and how innovators can better navigate the system; and
  • AHRQ’s role in promoting quality research and value exchanges and how these benefit innovators.

Resources